How to build a due diligence findings and risk tracker for Asset Purchase Transactions

Build a buyer-side diligence findings tracker around the assets the buyer needs, the liabilities it proposes to assume, and the evidence needed to evaluate both. Give each finding a stable ID, a precise source citation, a buyer-specific consequence, an accountable owner, and a documented disposition. The resulting deliverable connects diligence evidence to purchase agreement changes, transfer requirements, and expressly accepted risks. It should distinguish unresolved evidence gaps from verified problems and show what must happen before the buyer can make an informed decision.

When to use this workflow

Use this workflow when buyer’s counsel starts substantive review of an asset purchase data room or when an existing diligence report no longer identifies outstanding decisions. It suits in-house teams coordinating specialists and outside lawyers translating findings into negotiation positions.

Keep the scope on findings and risk decisions. Link to request logs, contract comparisons, and closing checklists rather than reproducing them. The tracker should answer whether the buyer will obtain usable assets, what obligations accompany them, and what uncertainty remains.

This is a general US legal-workflow guide, not advice for a particular transaction. Governing law, asset location, seller organization, industry, and structure require separate review of applicable transfer, lien, tax, employment, permit, and successor-liability rules. The cited agreements illustrate negotiated wording, not market standards.

What you need

Start with the current asset purchase agreement, purchased- and excluded-asset schedules, assumed- and excluded-liability definitions, disclosure schedules, and buyer operating plan. Identify the contracts, equipment, intellectual property, premises, permits, records, and shared services needed after closing.

Collect ownership evidence, lien information, executed contracts and amendments, employee materials, environmental records, and proposed consents or transition arrangements. Obtain the request log and seller responses, distinguishing unavailable records from express negative responses.

Maintain a document index with stable IDs, entity names, execution status, version dates, data-room locations, and amendment links. Preserve superseded versions so earlier decisions remain traceable.

Check access constraints before requesting interviews or additional materials. Section 5.1 of the Sensata–Cypress agreement provides negotiated access, limits burdensome information creation, and requires seller consent before unilateral employee contact. A diligence request list is not an equivalent access covenant. (sec.gov)

Use the template

The Asset Purchase Transactions — Diligence findings tracker is the working record for this workflow. Copy this table into your working document or spreadsheet. Use one row per independently resolvable finding, not one row per document.

Assign finding IDs such as F-001 and source references such as D-014, executed version, §8.2, page 6. Identify the relevant purchase agreement draft by date or version. A folder name alone is insufficient.

In Fact / gap, distinguish document text, seller assertions, missing evidence, and counsel’s analysis. Impact / priority explains the buyer consequence before assigning urgency. A low-cost software license may be critical if the production line depends on it.

Liability / transfer records both allocation and transfer obstacles; neither answers the other. Action / protection states the next request and proposed response. Owner / target names one accountable person and an internal decision point or verified deadline. Status / evidence preserves the disposition, supporting evidence, approval, and continuing uncertainty.

Link longer analysis by finding ID. Keep enough information in the row for a decision-maker to understand why the issue matters.

Step by step

1. Set the acquisition perimeter and priority criteria

Compare the purchased-assets definition and schedules with the operating plan. Identify dependencies outside that perimeter: a retained trademark, shared software account, warehouse access, or technical records needed to service transferred products.

Ask the business team which assets must be usable on day one and which can transfer later. Check whether equipment descriptions, serial numbers, locations, and owning entities match the proposed transfer documents.

Agree qualitative priorities tied to consequences and decision timing. Reserve the highest priority for potential operating interruption, significant exposure, or an unresolved issue requiring a signing or closing decision; avoid unsupported probability scores.

Record: the affected asset, operating dependency, buyer consequence, provisional priority, and scope question. Do not characterize an omitted asset as purchased merely because the business expects to use it.

2. Establish the source and separate fact from uncertainty

Review each operative document with its amendments, schedules, and side letters. Capture the relevant clause or page and check execution status. If documents conflict, cite both and identify the conflict rather than selecting the preferred version.

Distinguish “not provided,” “seller states none exists,” and “reviewed document contains no provision.” These describe different evidence conditions. A missing amendment may prevent a consent conclusion even where the original contract appears clear.

Make follow-up specific: request the identified amendment, ownership instrument, release, or explanation of conflicting asset descriptions. Do not substitute a broad request for a defined evidence gap.

Record: the verified fact, source version, uncertainty, targeted request, and preliminary priority. State which conclusion remains unavailable until the evidence arrives.

3. Map liability timing separately from transferability

Compare underlying obligations with the purchase agreement’s assumed- and excluded-liability language. Identify pre-closing breaches, post-closing performance, accrued payment obligations, and any delayed-transfer period.

The Ellie Mae–AllRegs agreement, §§1.3–1.4, distinguishes post-closing assigned-contract obligations from excluded pre-closing obligations and breaches, with separate timing for later-transferred contracts. This illustrates contractual allocation, not elimination of third-party exposure. (sec.gov)

Test ambiguous items individually: customer credits, warranties, deposits, prepaid services, and outstanding purchase orders may require different treatment under the actual wording. Identify the relevant allocation clause rather than writing only “excluded liability.”

Record: the obligation, proposed allocation, timing boundary, disputed treatment, and responsible reviewer. Where transfer occurs after closing, analyze that actual boundary rather than using “post-closing” as shorthand.

4. Identify barriers to obtaining usable assets

Review assignment restrictions, consent versus notice, permit questions, lien releases, and shared-service dependencies. Separate the underlying instrument’s requirements from applicable-law questions requiring specialist review. Request evidence of the solution, not confirmation that someone is “handling consent.”

Section 5.10 of the Ellie Mae–AllRegs agreement addresses specified nonassignable contracts and includes a limited recourse waiver for closing without particular scheduled consents. Neither its transfer arrangements nor its waiver should be assumed to apply elsewhere. (sec.gov)

For any proposed interim arrangement, ask who performs, receives payment, bears costs, and controls enforcement. Assign unresolved permissibility questions before treating the arrangement as operationally sufficient.

Record: the obstacle, dependency, proposed cure, evidence needed, and buyer approval required to proceed with a gap. Cite the relevant agreement version and underlying instrument.

5. Convert findings into decisions and protections

State the buyer decision plainly: require consent, revise assumed liabilities, commission specialist review, negotiate transition support, reconsider economics, or accept a defined residual risk. Explain how the proposed response addresses the consequence.

Do not treat indemnification as removal of the underlying exposure. 42 U.S.C. §9607(e)(1) prevents contractual arrangements from transferring away liability imposed by that CERCLA section while preserving agreements to insure, hold harmless, or indemnify. Buyer exposure and available statutory protections require separate analysis. (govinfo.gov)

Where monetary protection is proposed, identify the relevant coverage, limitations, claim mechanics, and recovery concerns in the actual draft. Keep those questions separate from whether the buyer can operate the acquired business.

Record: the requested protection, fallback, decision-maker, and remaining exposure. Cross-reference related findings so a schedule exception or liability amendment does not undermine another proposed solution.

6. Assign follow-up and define resolution evidence

Give each finding one accountable owner, even when several specialists contribute. Set the next action and target against the transaction timetable. Label internal targets and distinguish them from contractual deadlines.

Define closure evidence in advance. Executed consent, corrected schedules, a specialist conclusion, and authorized risk acceptance resolve different questions. A drafted certificate does not verify its underlying statements.

The Sensata–Cypress agreement, §§6.1–6.2, distinguishes jointly waivable conditions from buyer-waivable conditions and specifies buyer-condition deliverables. Use this example to separate satisfaction, supporting evidence, and waiver authority—not as a universal checklist. (sec.gov)

Record: owner, next action, target, required evidence, and approval authority. Link any closing-condition issue to the separate conditions record without declaring it satisfied prematurely.

7. Reconcile findings before reporting decisions

Before a negotiation or approval meeting, reconcile findings against the latest agreement, schedules, and transfer documents. Confirm whether revised language resolves the issue, reallocates it, or merely discloses it.

Use distinct statuses: open, awaiting evidence, decision required, resolved, and accepted residual risk. Preserve approval and reasoning when risk is accepted. Reopen a finding when new evidence or an operating assumption changes its basis.

Report the highest-priority decisions, the evidence still missing, and the consequence of proceeding without it. Do not equate the number of closed rows with readiness to sign or close.

Record: disposition, resolution source, residual uncertainty, and any continuing action’s destination and owner. Hand off deferred matters without labeling the underlying problem cured.

Worked example

Fictional scenario: Alder Quay Components LLC proposes to acquire a manufacturing facility, equipment, selected contracts, and scheduled receivables from Briar Vale Instruments Inc. for $18 million. The buyer expects immediate production. All parties, documents, amounts, and clauses below are fictional.

The draft excludes historical liabilities. Review identifies a software consent issue, a disputed credit against an acquired receivable, and incomplete environmental information. The buyer initially suggests a general seller indemnity for all three.

The findings require different decisions. F-001 concerns usable access, so monetary recourse alone does not answer the operating question. F-002 concerns acquired receivable value and allocation; the customer email does not prove the credit is valid. F-003 remains an assessment gap, not a finding of contamination or established buyer liability.

The tracker therefore replaces “broaden indemnity” with specific evidence requests and decision paths. None is resolved merely because a request was sent or an exclusion drafted.

Common mistakes

• One row covers an entire asset category. Split ownership, transfer, and liability findings when their evidence or remedies differ.
• Disclosure is treated as a cure. Record what the disclosure changes and which buyer consequence remains.
• Missing evidence becomes “no issue.” Keep the uncertainty visible and assign a targeted request.
• Excluded liability ends the analysis. Separate contractual allocation from external exposure and economic effects on acquired assets.
• A draft or assurance closes the finding. Identify the evidence appropriate to the decision and preserve any accepted uncertainty.

Final quality check

• Each finding identifies an asset, operating dependency, or potentially assumed obligation.
• Source references identify the operative version and verified clause or page.
• Facts, seller statements, missing evidence, and analysis remain distinguishable.
• Priority reflects a stated buyer consequence and acknowledges uncertainty.
• Proposed protections address the issue under the current agreement wording.
• Every open issue has an owner, next action, and decision target.
• Closure or risk acceptance retains evidence, approval, and assigned continuing actions.

Complete the workflow with DecoverAI

DecoverAI is the Legal Intelligence Platform for litigation and transactions. Its due diligence capabilities support bulk document classification to organize materials and prioritize human review; tabular review supports analysis across documents. In contract review, lawyers can choose the represented party in Word and provide deal-specific instructions. Findings quote and locate clauses, rank severity, and identify missing language as not present. Lawyers decide which suggestions to edit or insert as ordinary tracked changes and which findings to dismiss. The tracker and risk decisions remain the team’s work product. To assess fit with your buyer-side workflow, book a demo.

Frequently asked questions

Should every reviewed document produce a finding?

No. Record review coverage in the document index. Create findings for risks, material uncertainties, or decisions; routine coverage entries otherwise obscure buyer action items.

How should one issue affecting several assets be recorded?

Use a shared finding with linked asset-specific entries where evidence or remedies differ. Confirm each consent’s scope before treating several contracts as resolved together.

Can a finding close before consent arrives?

Not as cured. If an authorized buyer representative accepts proceeding, record accepted residual risk, approval, consequences, and continuing action. Review the actual agreement’s waiver and recourse language.

What if seller and buyer disagree about priority?

Preserve the seller’s explanation, but assess priority against the buyer’s operating plan and evidence. Escalate the decision to the designated buyer representative rather than averaging competing labels.

Sources

• Sensata–Cypress Asset Purchase Agreement, §§5.1 and 6.1–6.2: negotiated access and condition examples.
• Ellie Mae–AllRegs Asset Purchase Agreement, §§1.3–1.4 and 5.10: liability timing and consent examples.
• 42 U.S.C. §9607(e)(1): contractual allocation and CERCLA liability.

This guide is general information about legal workflows, not legal advice for any matter. It was drafted and reviewed with AI assistance. The worked example is fictional. Contract rights and procedure depend on the governing law, the actual wording, and the facts, so check the cited sources and the rules that apply in your jurisdiction before relying on it.